Patents by Inventor Anup Ray

Anup Ray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080021200
    Abstract: The present invention relates to an improved process for preparing a polypeptide or pharmaceutically acceptable salt thereof comprising L-tyrosine, L-alanine, L-glutamate, and L-lysine. The polypeptide or pharmaceutically acceptable salt thereof is preferably glatiramer acetate.
    Type: Application
    Filed: September 27, 2007
    Publication date: January 24, 2008
    Inventors: Anup Ray, Hiren Patel, Johannes Ludescher, Mariappan Anbazhagan, Mahendra Patel, Ingolf Macher
  • Publication number: 20070173496
    Abstract: The invention provides an Olanzapine pseudopolymoph Form E. The invention provides methods of preparing polymorphic Olanzapine Form E employing rapid crystallization and seeding. The invention provides methods of preparing anhydrous Olanzapine Form I from the Olanzapine Form E by step-wise drying.
    Type: Application
    Filed: January 26, 2006
    Publication date: July 26, 2007
    Inventors: Anup Ray, Hiren V. Patel, Johannes Ludescher, Mahendra Patel
  • Publication number: 20060154862
    Abstract: The present invention relates to processes for preparing a polypeptide or pharmaceutically acceptable salt thereof comprising L-tyrosine, L-alanine, L-glutamate and L-lysine. The polypeptide or pharmaceutically acceptable salt thereof is preferably glatiramer acetate.
    Type: Application
    Filed: October 28, 2005
    Publication date: July 13, 2006
    Inventors: Anup Ray, Hiren Kumar Patel, Johannes Ludescher, Mariappan Anbazhagan, Mahendra Patel, Ingolf Macher
  • Publication number: 20050008704
    Abstract: The present invention provides a pharmaceutical composition having enhanced solubility comprising a drug and polyethylene glycol, wherein the ratio of polyethylene glycol to drug by weight is from about 0.2:1 to about 10:1, and the polyethylene glycol has a melting point of at least 37° C. The pharmaceutical compositions exhibit rapid dissolution upon contact with physiological solvents, such as water, saliva or gastrointestinal fluids.
    Type: Application
    Filed: July 11, 2003
    Publication date: January 13, 2005
    Inventors: Anup Ray, Indranil Nandi, Suresh Palaniswamy, Pablo Davila, Aakanksha Vora